Elite Health Systems Inc. awarded CEO jeereddi Prasad Anjaneya 68,421 derivative securities on 2026-08-31, lifting his resulting derivative-securities holding to 178,947. For investors tracking executive ownership, the award represented about 38.2% of that post-transaction holding, quantifying the transaction against the CEO's disclosed position.

Key Highlights

  • The transaction was recorded on 31 August 2026 under code A, denoting an award or grant.
  • The award represented about 38.2% of the CEO's resulting derivative-securities holding.
  • Elite Health Systems CEO jeereddi Prasad Anjaneya received 68,421 derivative securities in an award dated 31 August 2026.

After the transaction, Anjaneya held 178,947 derivative securities, while the award represented about 38.2% of that resulting holding.

Award Classified as Code A

The transaction record identifies jeereddi Prasad Anjaneya as Elite Health Systems Inc.'s chief executive officer. The securities involved are derivative securities, and the award date was 31 August 2026. Anjaneya's resulting position was 178,947 derivative securities. The award represented about 38.2% of that resulting holding.